A Randomized Clinical Evaluation of the BioFreedom™ Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2456 participants.

Also called NCT01623180

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,456 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01623180
Other papers using this trial's data
  • 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents Journal of the American College of Cardiology, 2017-01-17 DOI, PubMed 27806919
  • Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk The New England journal of medicine, 2015-11-19 DOI, PubMed 26466021
  • Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial Clinical research in cardiology : official journal of the German Cardiac Society, 2019-01 DOI, PubMed 29951803
  • Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy JACC. Cardiovascular interventions, 2017-08-28 DOI, PubMed 28838473

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01623180. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2015-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Clinical Evaluation of the BioFreedom™ Stent
Acronym
Leaders Free
Condition
Stable Angina
Condition
Ischemic Heart Disease Silent
Condition
ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction
Condition
In-stent Coronary Artery Restenosis
Condition
Bleeding
Intervention (Device)
Biofreedom™ Drug Coated Stent (DCS)
Intervention (Device)
Gazelle™ Bare Metal Coronary Stent (BMS)
Lead sponsor
Biosensors Europe SA (class: industry)
Collaborator
European Cardiovascular Research Center (class: research network)

Record details

Record id
cardio:ct-nct01623180
Content hash
28ebbedf15f7ff2204b3ced80fb4d82a2000a52f126760c1e58fc97a3c18b54f